Purchase Order HHSN302201800054P

Award Date 1/25/18
Potential Completion Date 4/11/18
Potential Value $18K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This $16,035 firm-fixed price purchase order was awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the U.S. Department of Health and Human Services, to MedChemExpress LLC, a New Jersey-based foreign-owned minority-owned small business. The award is for the acquisition of 2 grams of Minnelide (CAS: 1254702-87-8) and 10 grams of GNE-618 (CAS: 1362151-42-5), which are chemical compounds used to support NCATS' biomedical research programs. MedChemExpress has...
This is a $24,900.00 firm fixed price purchase order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Drug Abuse to Chemogenics Biopharma, LLC, a for-profit limited liability company and sole proprietorship, on July 23, 2019. The contract has a completion date of September 30, 2019 and does not have a set-aside designation. Chemogenics Biopharma, LLC is a leading company in preclinical drug discovery and has been awarded several...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The contract is for the supply of FYCOMPA 0.5 MG/ML oral suspension (340 mL) with a potential value of $1,924.48 and a completion date of February 28, 2024. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp holds an Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of FYCOMPA 8 MG Tablet 30S, a pharmaceutical product. The award has a firm fixed price of $2,409.37 and an ultimate completion date of March 21, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The award is part of a larger indefinite delivery contract (IDC)...
This federal contract award is for the delivery of FYCOMPA 0.5 MG/ML oral suspension in 340 ML bottles to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, and has a ceiling value of $5,773.44. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued up to $999,999,999.00...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $11,006.95, is for the delivery of LENVIMA 20 MG DAILY DOSE 60S, a specialized pharmaceutical product. The contract has a completion date of February 14, 2025 and is not associated with any set-aside designations. DMS Pharmaceutical Group Inc. holds a significant...
<p>This is a Small Business Innovation Research (SBIR) Phase I contract awarded by a U.S. government agency to Provid Pharmaceuticals Inc., a for-profit organization, in the amount of $199,922.00. The contract is for &quot;Medicinal Chemistry Lead Optimization&quot; research, with a completion date of June 29, 2007. The contract is a Firm Fixed Price Definitive Contract, with the place of performance being North Brunswick Township, NJ.</p>
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $8,026.53, is for the delivery of PROMACTA 50 MG TABLET UU 30S, a prescription medication, to support the medical supply needs of military healthcare facilities. The contract has a completion date of February 19, 2025 and is not associated with any set-aside designation. DMS...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $3,261.18 for the supply of FYCOMPA 0.5 MG/ML ORAL SUSP 340ML. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. The contract is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award, with an identifier of SPE2DX15D8002|SPE2DX24F2VZ6, is for the delivery of REYVOW 100 MG TABLET UD 8S, a pharmaceutical product, to the Medical Supply Chain, a program of the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The contract, valued at $1,832.91, was awarded on April 23, 2024 to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The...

ENHANCED PHARMACODYNAMICS LLC:1285086 [18-002653]

Posted 1/25/18, 12:00 AM